NDC 45963-461

NDC 45963-461

NDC 45963-461 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 45963-461
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 45963-461-10 [45963046110]

Lansoprazole CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA201921
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-01-18
Marketing End Date2018-10-31

NDC 45963-461-96 [45963046196]

Lansoprazole CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA201921
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-01-18
Marketing End Date2014-11-30

NDC 45963-461-03 [45963046103]

Lansoprazole CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA201921
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-01-18
Marketing End Date2018-12-31

Drug Details

Medicade Reported Pricing

45963046196 LANSOPRAZOLE DR 30 MG CAPSULE

Pricing Unit: EA | Drug Type:

45963046110 LANSOPRAZOLE DR 30 MG CAPSULE

Pricing Unit: EA | Drug Type:

45963046103 LANSOPRAZOLE DR 30 MG CAPSULE

Pricing Unit: EA | Drug Type:
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.